Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2014. Start Trial.
Date Value
September 30, 2026 93.02%
August 31, 2026 91.75%
July 31, 2026 91.75%
June 30, 2026 91.75%
May 31, 2026 90.24%
April 30, 2026 90.24%
March 31, 2026 90.24%
February 28, 2026 89.79%
January 31, 2026 89.79%
December 31, 2025 89.79%
November 30, 2025 89.79%
October 31, 2025 89.79%
September 30, 2025 88.84%
August 31, 2025 88.84%
July 31, 2025 88.84%
June 30, 2025 88.84%
May 31, 2025 24.55%
April 30, 2025 24.55%
March 31, 2025 24.55%
February 28, 2025 24.55%
January 31, 2025 24.55%
December 31, 2024 24.55%
November 30, 2024 24.55%
October 31, 2024 24.55%
September 30, 2024 24.55%
Date Value
August 31, 2024 24.55%
July 31, 2024 24.55%
June 30, 2024 24.55%
May 31, 2024 24.55%
April 30, 2024 24.55%
March 31, 2024 24.55%
February 29, 2024 24.55%
January 31, 2024 24.55%
December 31, 2023 24.55%
November 30, 2023 24.55%
October 31, 2023 24.55%
September 30, 2023 24.55%
August 31, 2023 24.55%
July 31, 2023 24.55%
June 30, 2023 24.55%
May 31, 2023 24.55%
April 30, 2023 24.55%
March 31, 2023 24.55%
February 28, 2023 19.96%
January 31, 2023 19.96%
December 31, 2022 19.96%
November 30, 2022 19.96%
October 31, 2022 19.96%
September 30, 2022 19.96%
August 31, 2022 19.96%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lonza Group AG 59.15%
Bachem Holding AG --
PolyPeptide Group AG --
Lifecore Biomedical, Inc. 89.19%
Novartis AG 20.42%